Engineering TCR & CAR-T Cells Through Hematopoietic Stem Cells

Time: 4:15 pm
day: Day 2 - Track B - Evening


• Engineering blood forming (hematopoietic) progenitors with TCRs or CARs to target chronic viral infection or malignancies to create an infinite source of T-cells
• Demonstrating long-term benefit and T-cell persistence in humanised mice and nonhuman primate models
• Demonstration of safety and efficacy and the next steps in clinical translation